12/4
05:36 am
cprx
Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]
Low
Report
Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]
12/3
05:38 pm
cprx
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]
Low
Report
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]
11/28
01:37 am
cprx
A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
11/24
08:03 am
cprx
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
Low
Report
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
11/19
08:03 am
cprx
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
Low
Report
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
11/18
08:03 am
cprx
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
Low
Report
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
11/16
01:09 am
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at
Wall
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at
Wall
11/15
07:05 pm
cprx
Is Catalyst Pharmaceuticals Still a Bargain After Pipeline Expansion and 8% Weekly Gain? [Yahoo! Finance]
Low
Report
Is Catalyst Pharmaceuticals Still a Bargain After Pipeline Expansion and 8% Weekly Gain? [Yahoo! Finance]
11/7
04:03 pm
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its price target raised by analysts at Citigroup Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its price target raised by analysts at Citigroup Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
11/7
09:05 am
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
11/5
04:06 pm
cprx
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
11/4
04:03 pm
cprx
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
Low
Report
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
11/3
08:03 am
cprx
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
Low
Report
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
10/22
08:03 am
cprx
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
Medium
Report
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
10/13
11:34 pm
cprx
Catalyst Pharmaceuticals Shares Climb as New Drug Developments Spark Fresh Valuation Debate [Yahoo! Finance]
Low
Report
Catalyst Pharmaceuticals Shares Climb as New Drug Developments Spark Fresh Valuation Debate [Yahoo! Finance]
10/12
01:08 am
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at
Wall
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at
Wall
10/9
08:33 am
cprx
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences [Yahoo! Finance]
Low
Report
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences [Yahoo! Finance]
10/9
08:03 am
cprx
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
Low
Report
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
10/9
01:09 am
cprx
Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia [Yahoo! Finance]
Low
Report
Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia [Yahoo! Finance]
10/8
01:09 am
cprx
What do Analysts Think About Catalyst Pharmaceuticals (CPRX)? [Yahoo! Finance]
Low
Report
What do Analysts Think About Catalyst Pharmaceuticals (CPRX)? [Yahoo! Finance]
10/4
03:06 am
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) was downgraded by analysts at
Wal
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) was downgraded by analysts at
Wal
10/3
01:10 am
cprx
Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy [Yahoo! Finance]
Low
Report
Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy [Yahoo! Finance]
10/2
08:05 am
cprx
Health Canada Approves AGAMREE® (vamorolone) as the First Treatment for Duchenne Muscular Dystrophy in Canada [Yahoo! Finance]
Medium
Report
Health Canada Approves AGAMREE® (vamorolone) as the First Treatment for Duchenne Muscular Dystrophy in Canada [Yahoo! Finance]
10/1
11:55 am
cprx
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
10/1
08:34 am
cprx
Catalyst Pharmaceuticals announces $200M share repurchase program through 2026 [Seeking Alpha]
Medium
Report
Catalyst Pharmaceuticals announces $200M share repurchase program through 2026 [Seeking Alpha]